FMP
Pulse Biosciences, Inc.
PLSE
NASDAQ
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
17.98 USD
0.19 (1.06%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Robert W. Duggan
sector
Healthcare
industry
Medical - Instruments & Supplies
exchange
NASDAQ
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
CIK
0001625101
ISIN
US74587B1017
CUSIP
74587B101
Address
3957 Point Eden Way
Phone
510 906 4600
Country
US
Employee
56
IPO Date
May 18, 2016
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
PLSE Financial Summary
CIK
0001625101
Exchange
NASDAQ
Industry
Medical - Instrument...
Sector
Healthcare
CUSIP
74587B101
ISIN
US74587B1017
Country
US
Price
17.98
Beta
1.75
Volume Avg.
164.67k
Market Cap
1.11B
Shares
-
52-Week
6.595-22.69
DCF
0.73
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-21.66
P/B
-
Website
https://www.pulsebiosciences.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest PLSE News
It looks like there's no news available.
